Directed editing of cellular rna via nuclear delivery of crispr/cas9

Authors: Yeo, Eugene; Brannan, Kristopher; Marina, Ryan; Nelles, David;
Patent

Publisher: Google Patents

Abstract

Disclosed herein is a technology to perform programmable RNA editing at single-nucleotide resolution using RNA-targeting CRISPR/Cas9. This approach, which Applicants have termed "Cas9-directed RNA editing" or "CREDIT," provides a means to reversibly alter genetic information in a temporal manner, unlike traditional CRISPR/Cas9 driven genomic engineering which relies on permanently altering DNA sequence.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy